News
Swiss Deep Tech News & Analysis
Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.
Curated Newsfeed
-
Adaptyv raises $40M to build automated lab for agentic biology
startupticker.ch
-
Lookthrough acquires BuildingMinds from Schindler
startupticker.ch
-
Gravis Robotics Raises $200M for Construction Autonomy
startupticker.ch
-
Indivi attracts Infosys Innovation Fund as strategic investor
startupticker.ch
-
Bruker makes minority investment in Atinary
startupticker.ch
-
Boehringer Ingelheim acquires equine health startup Evax
startupticker.ch
DTN Highlights
-
Read more: swisscanto: A Matter of ScaleThe Flywheel Switzerland Hasn’t Built Roughly seventy percent of the Swiss Growth Fund’s money is invested in Switzerland, and Nils Granath is clear that this…
-
Read more: swisscanto: Backed to the FutureThree Companies That Almost Stopped Running Nils Granath invests in the growth stage of the Swiss market, and it is the part where the money…
-
Read more: swisscanto: At Face ValueThe Marathon Runner In the mid-1990s, the European mobile telecoms industry was hiring at a pace that was breaking its own buildings. Ericsson, the Swedish…
-
Read more: Swiss Venture Capital Steadies at $1.58 Billion in H1 2026 as Hardware Sets a RecordSwiss venture capital returned to a familiar level in the first half of 2026. Startups raised $1.58 billion (CHF 1.245 billion) across 123 financing rounds,…
-
Read more: Swiss Deep Tech Report 2026: Switzerland Leads the Technologies Reshaping the Global EconomyThe technologies now driving the global economy, advanced computing, artificial intelligence, and robotics, are built patiently, over decades of investment and scientific groundwork. So are…
-
Read more: Swiss Venture Capital Matures: Returns, Exits, and a Sharper Investor LayerSwiss venture capital recorded its first annual rebound since 2022 last year, with CHF 2.95 billion invested and a record CHF 1.116 billion flowing into…
-
Read more: Bridging the tough middle: Key takeaways from the Deep-Tech x Space SummitESA chose ESDI at Park Innovaare for its first dedicated Deep-Tech × Space Summit on 13 May 2026. Deep Tech Nation Switzerland CEO Joanne Sieber…
-
Read more: SICTIC: A Matter of ScaleIn Parts 1 and 2 of our series, we followed Thomas Dübendorfer from a student fund at ETH Zurich to SICTIC, Switzerland’s largest angel investor…
-
Read more: SICTIC: Backed to the FutureThomas Dübendorfer doesn’t invest like a portfolio manager optimizing for returns. He invests like a scout who found someone worth running alongside – and then…
-
Destinus and Daedalean sign CHF 180 million acquisition deal
Aiming to accelerate the development of smarter AI-based flight systems for advanced autonomous operations, Destinus has acquired Zurich-based Daedalean, a leader in aviation AI solutions,…
startupticker.ch
startupticker.ch: Destinus and Daedalean sign CHF 180 million acquisition deal- Destinus acquired Zurich-based Daedalean for CHF 180M to integrate AI avionics with UAV manufacturing.
- Daedalean's safety-critical AI enables autonomous piloting, environmental awareness, and GNSS-denied navigation.
- The combined company will accelerate intelligent UAV development with swarm intelligence and advanced decision-making.
-
Modulos raises CHF 8.7 million pre-series A to scale AI governance platform
Modulos, the leading AI governance platform, has finalized its CHF 8.7 million pre-Series A funding round. The investment positions the company to capitalize on the…
startupticker.ch
startupticker.ch: Modulos raises CHF 8.7 million pre-series A to scale AI governance platform- Modulos raised CHF 8.7 million in pre-Series A funding to automate AI governance and compliance ahead of EU AI Act enforcement in August 2026.
- The platform is the first AI governance solution with ISO 42001 product conformity certification for managing multiple compliance frameworks.
- Modulos participates in global regulatory bodies including the EU AI Office and NIST to shape AI governance standardization.
-
CHF 10.1 million to advance a zero-emission electric fast ferry
MobyFly has announced the closing of its CHF10.1 million Series A financing round, including a significant contribution from the Environmental and Solidarity Revolution Fund, supported…
startupticker.ch
startupticker.ch: CHF 10.1 million to advance a zero-emission electric fast ferry- MobyFly raised CHF10.1 million Series A funding led by Crédit Mutuel to commercialize zero-emission hydrofoil technology.
- MobyFly's electric hydrofoils use 80% less energy, cut operating costs 60% vs diesel ferries, and travel over 70 km/h.
- MobyFly will expand engineering and R&D to bring its sustainable maritime transport solution to global markets.
-
$6.5 million to accelerate the future of domain names and digital Identity
Freename, the startup building the world’s first Unified Internet, where a domain name functions as the universal access key across Web2 and Web3 utilities, has…
startupticker.ch
startupticker.ch: $6.5 million to accelerate the future of domain names and digital Identity- Freename raised $6.5M in Series A to enable domain names as universal access keys across Web2 and Web3.
- Freename obtained ICANN Registrar License and launched on-chain DNS readable by traditional browsers.
- Freename resolves domain collisions across blockchains and supports Polygon, Solana, Base, and BNB Chain.
-
Pharvaris secures over $200 million to advance clinical developments
Pharvaris has raised about $201.2 million through an upsized public offering of its shares, including the sale of over 9.5 million ordinary shares and pre-funded…
startupticker.ch
startupticker.ch: Pharvaris secures over $200 million to advance clinical developments- Pharvaris raised $201.2M via public offering to fund oral bradykinin B2 receptor antagonist for hereditary angioedema.
- The company runs two Phase 3 trials for deucrictibant: one for HAE attack prevention, one for on-demand treatment.
- Proceeds will fund late-stage trials, build U.S. sales team, and cover commercialization expenses.
-
German optics giant acquires Pi imaging Technologies
Carl Zeiss Microscopy GmbH, based in Germany, has acquired all equity shares and employees of Pi Imaging Technologies SA. The Lausanne-based startup is known for…
startupticker.ch
startupticker.ch: German optics giant acquires Pi imaging Technologies- Carl Zeiss Microscopy acquired Pi Imaging Technologies, a Lausanne startup known for developing the first commercial SPAD camera for detecting individual photons.
-
Cleantech startups validate their technologies on land and water
Restor has launched a project with Guatemala government to monitor over half a million hectares and 83,000 sites by 2030 while Neustark launched its first…
startupticker.ch
startupticker.ch: Cleantech startups validate their technologies on land and water- Restor partnered with Guatemala to monitor 520,000 hectares and 83,000 restoration sites, benefiting 285,000 people by 2030.
- Synhelion fueled a car with solar gasoline for the first time, proving renewable synthetic fuel works in existing engines.
- Neustark launched France's first facility storing CO2 in recycled clinker, capturing up to 1,200 tonnes annually by 2026.
-
CHF 1.5 billion for Swiss start-ups – high-flyers ensure good numbers
CHF 1.47 billion in venture capital went to Swiss start-ups in the first half of 2025, the third best result ever. A small handful of…
startupticker.ch
startupticker.ch: CHF 1.5 billion for Swiss start-ups – high-flyers ensure good numbers- Swiss start-ups raised CHF 1.47 billion in H1 2025, third-best ever, but driven by large deals rather than broad funding growth.
- Biotech dominated with record CHF 705 million invested; ICT and fintech recovered, but financing rounds declined for third consecutive period.
- Swiss VC investors expect worsening conditions for fundraising and exits, but show limited concern about U.S.
-
CHF 79 million to advance Nuclidium’s copper-based radiopharmaceutical platform
NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, has closed its Series B financing round led by Kurma Growth Opportunities Fund.…
startupticker.ch
startupticker.ch: CHF 79 million to advance Nuclidium’s copper-based radiopharmaceutical platform- NUCLIDIUM raised CHF 79 million in Series B funding for its copper-based radiopharmaceutical platform for cancer diagnostics and therapeutics.
- NUCLIDIUM's 61Cu-based imaging outperforms approved PET tracers with superior lesion detection and tumor-to-background ratios in early clinical data.
- The company plans to expand manufacturing globally and strengthen collaborations across Europe and North America with the new funding.
-
Wefox secures EUR 151 million funding
Following the successful completion of the wefox’s business restructuring program, the insurtech company secured EUR 151 million. This consisted of a EUR 76 million capital…
startupticker.ch
startupticker.ch: Wefox secures EUR 151 million funding- Wefox raised EUR 151 million through capital and credit refinancing, positioning the insurtech company for 2025 profitability.
- Wefox completed restructuring by divesting Liechtenstein and Italy operations to focus on Austria, Netherlands, and Switzerland.
- Wefox's asset-light MGA model targets sustainable growth by strengthening partnerships with insurance companies and brokers.
-
Additional funding brings Comphya’s series A to CHF 7.5 million
Comphya SA, a Lausanne-based company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED) unresponsive to medication, has closed an oversubscribed Series A financing…
startupticker.ch
startupticker.ch: Additional funding brings Comphya’s series A to CHF 7.5 million- Comphya raised CHF 7.5M Series A to develop CaverSTIM, an implantable neurostimulation device for medication-resistant erectile dysfunction.
- Australian trials showed CaverSTIM maintained erectile function post-prostatectomy with no infections or adverse events.
- FDA approved pilot study at Johns Hopkins; company plans pivotal trial in 2026 with Series B funding.
-
EvlaBio secures €21 million in seed funding
EvlaBio closed a €21 million seed funding to complete preclinical development of a monoclonal antibody for the treatment of left ventricular hypertrophy in the setting…
startupticker.ch
startupticker.ch: EvlaBio secures €21 million in seed funding- EvlaBio secured €21M seed funding for a monoclonal antibody targeting FGF23/FGFR4 signaling in chronic kidney disease.
- EvlaBio's novel approach targets cardiac pathways to address left ventricular hypertrophy resistant to current treatments.
- Funding will advance EvlaBio's first-in-class cardio-renal therapeutic toward IND-enabling studies.
-
Read more: Swiss AI Enters a New Era: inait SA and the Rise of Digital BrainsSwiss AI startup inait is redefining artificial intelligence by building digital brains—software systems that simulate human reasoning. Backed by Microsoft and rooted in neuroscience from…
-
Read more: CUTISS: A Swiss Techbio Champion Ready to Lead the Global Health RevolutionCUTISS is reshaping the future of skin surgery with denovoSkin™, a groundbreaking techbio innovation born in Switzerland. As it nears global commercialization, CUTISS highlights both…
-
Read more: Success Story: Péter FankhauserANYbotics’ Péter Fankhauser takes on Boston Dynamics with robot dogs built for dangerous inspections—backed by $60M and global clients.
-
Read more: Millions for Research but no Money for Growth: Swiss Startups are Looking Abroad for InvestorsTranslated from NZZ, this article explores why Swiss startups often seek growth capital abroad despite strong local innovation roots.
-
Read more: How Swiss Startups are Making Their Mark on Agentic AIDiscover how Swiss startups are leading the crowded agentic AI space with cutting-edge, goal-driven AI agents tailored for finance, law, gaming, and software—powered by scientific…
-
Read more: Swiss Deep Tech Venture Capital: The 2025 EU Deep Tech ReportEurope’s deep tech ecosystem has become a potent driver of innovation, standing strong despite broader venture capital market fluctuations. Switzerland is gaining recognition as a…
-
Read more: Deep Tech: The Engine of Disruptive InnovationDeep tech is at the forefront of technological evolution, driving breakthroughs that redefine industries and address complex global challenges. Unlike traditional tech startups that often…
-
Read more: What Can We Learn From W.A. De Vigier Awards 2025 FinalistsDiscover insights about the Swiss Innovation ecosystem through an analysis of the W.A. De Vigier Startup Funding Competition Finalists
-
Read more: Unlocking Swiss Deep Tech for Institutional InvestorsThe AWI Deep Tech Fund is bridging the gap between Swiss tech and institutional investors. Discover how it’s unlocking new opportunities.
-
Read more: Swiss AI and the New Autonomous Driving RegulationAs unsurprising as it will sound to people familiar with Switzerland and its priorities, the country spends a lot of time debating, planning, and maintaining…
-
Read more: AWI and DTN Launch AWI DTF Fund Manager Request for ProposalsThe Anlagestiftung Winterthur für Personalvorsorge (AWI), in collaboration with Deep Tech Nation Switzerland (DTN), has launched a Request for Proposals (RfP) for the AWI Deep…
-
Read more: Switzerland: The Global Deep Tech LeaderSwitzerland was recently named a deep tech beacon by Forbes. Through data backed facts, discover why it’s even more than that; a global deep tech…
